Experience of Using Remdesivir in Patients with Novel Coronavirus Infection
Timely, effective, and safe antiviral therapy in COVID-19 patients reduces complications, disability and mortality rates. The greatest concern with remdesivir is the risk of drug-induced liver injury, including in patients whose liver function is compromised by COVID-19.The aim of the study was to i...
Saved in:
Main Authors: | V. I. Petrov, A. Yu. Ryazanova, N. S. Privaltseva, D. A. Nekrasov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2022-12-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/332 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020-09-01) -
POLYPHARMACY IN MANAGMENT OF IN-PATIENTS WITH NOVEL CORONAVIRUS DISEASE (COVID-19)
by: V. I. Petrov, et al.
Published: (2022-07-01) -
Predicting the risk of developing drug-induced liver injury during remdesivir therapy in COVID-19 patients using machine learning
by: Yu. V. Shevchuk, et al.
Published: (2024-12-01) -
Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19
by: V. I. Petrov, et al.
Published: (2024-10-01) -
Experience in Using Antiviral Agents for the Treatment of Novel Coronavirus Infection (COVID-19) in Kyrgyzstan
by: A. A. Zurdinova, et al.
Published: (2021-12-01)